Physician

Abdul A Ameen, MD

According to 2025 Medicare claims, Abdul Ameen, MD (NPI: 1457317844) practices cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is CARDIOVASCULAR ASSOCIATES OF HUDSON COUNTY PA (NPI: 1336363258; TIN: 010658404) and primary practice location at 07302-4397.

Ameen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 1,513 HCPCS/CPT codes, and received $101,233 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,171 prescription claims across 174 beneficiaries totaling $397,836 in drug costs, led by Eliquis (Apixaban). DME data shows 121 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $245,680 to $101,233. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $74,674 to $397,836. For DME billing, this smaller-volume category declined steadily, from $70,673 to $3,089.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	860	2,929	$245,680
2016	799	2,604	$223,244
2017	722	2,675	$241,524
2018	537	2,019	$220,599
2019	273	1,254	$124,722
2020	700	2,030	$143,482
2021	645	2,000	$163,929
2022	601	2,246	$140,932
2023	372	1,742	$111,417
2024	270	1,513	$101,233

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	134	1,573	$74,674
2016	131	1,416	$87,021
2017	146	1,318	$67,780
2018	134	1,436	$104,344
2019	137	1,449	$121,860
2020	132	1,077	$96,997
2021	137	1,254	$142,711
2022	155	1,246	$404,099
2023	142	1,124	$440,701
2024	174	1,171	$397,836

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	35	$70,673
2016	N/R	24	$43,971
2017	15	43	$83,377
2018	N/R	22	$43,720
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	43	$34,286
2023	N/R	110	$6,241
2024	N/R	121	$4,248

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	63	79	$141
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	108	261	$97
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	52	136	$17
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	122	239	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	65	90	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	102	5,849	$111,353
Farxiga	Dapagliflozin Propanediol	83	3,630	$67,667
Entresto	Sacubitril/Valsartan	26	1,500	$31,545
Multaq	Dronedarone Hcl	20	990	$25,393
Xarelto	Rivaroxaban	20	900	$16,811

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J2260	Injection, milrinone lactate, 5 mg	N	N/R	55	$2,032
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	55	$2,005
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	11	$211

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul A. Ameen, MD?

Tedicare shows public-source Medicare data for Abdul A. Ameen, MD (NPI 1457317844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul A. Ameen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul A. Ameen, MD?

Abdul A. Ameen, MD is linked to CARDIOVASCULAR ASSOCIATES OF HUDSON COUNTY PA (billing NPI 1336363258) in the available physician profile data.

Does Abdul A. Ameen, MD have Open Payments data?

Abdul A. Ameen, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.